ale.c04
Showing 1 - 1 of 1
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial (ALE.C04, Pembrolizumab)
Not yet recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- ALE.C04
- Pembrolizumab
- (no location specified)
Sep 19, 2023